The report “Psychosis Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”, has been prepared based on an in-depth market analysis with inputs from industry experts.
Psychosis is associated with the condition in which a person loses contact with the reality. The person becomes confused and cannot understand what is real. The primary symptoms include delusions and hallucinations. Psychosis is a condition that is experienced at some stage of life. In the US, approximately 100,000 youngsters are affected by psychosis every year. Factors responsible for causing psychosis can be genetics, trauma, substance use, physical illness, injury, or mental ill health.
Get Sample Copy Of This Report @ https://www.marketresearchreports.biz/sample/sample/8330
Psychosis treatment primarily involves medication and psychotherapy. Mediation targets symptoms of psychosis and helps reduce them, while psychotherapy helps individuals manage their conditions. Psychotherapeutic medication helps treat mental illnesses such as confused thinking, extreme mood swings, long-lasting depression, social withdrawal, and suicidal thoughts generally associated with mental disorders such as schizophrenia, bipolar disorder, anxiety, and depression. The global psychotherapeutic drugs market is expanding due to high prevalence of emotional and mental diseases worldwide. According to a WHO report, approximately 350 million people are suffering from depression and around 24 million people are affected by schizophrenia across the world to date. Patent expiration of top psychotic drugs viz. Prozac, Geodon, and Zyprexia has opened ways for manufacturers of generic drugs. In the next few years, the generics segment is likely to expand significantly. This would give rise to price competition in the psychotherapeutic drugs market. Psychiatry therapies basically rely on establishing a relationship between the patient and the psychiatry therapist for developing the patient’s behavioral insights. The psychiatry therapist uses psychological drugs or electric shocks to alter the emotions of the patient. Non-verbal and verbal communication with the patient and other physical intervention also prove to be beneficial in the treatment of psychiatry patients. In addition, adjuvant therapies such as music therapies and occupational therapies are also useful in the treatment. These all therapies aim to enhance the well-being of patients by employing a range of psychological techniques. According to Canadian Psychological Association (CPA), psychological treatment and therapies are very effective for the treatment of general anxiety disorder. High benefits of psychiatry therapies applied to cure a variety of disorders are likely to drive the psychosis treatment market during the forecast period. However, strict regulations about the practice of psychotherapies by different governments are projected to restrain the market from 2017 to 2025.
The global psychosis treatment market can be segmented based on psychotherapeutic medication and psychotherapy. Based on psychotherapeutics, the market can be segmented into antipsychotics (chlorpromazine, haloperidol), antidepressants (amitriptyline, clomipramine), antimaniacs (lithium, carbamazepine), and anxiety drugs (lorazepam, alprazolam). Antipsychotics is one of the rapidly expanding segments of the market, owing to growing incidence of mental disorders such as schizophrenia and bipolar disorder. Atypical antipsychotics are the most preferred antipsychotics, as they are more efficacious than first-generation antipsychotics. Top-selling antipsychotic drugs include Abilify, Seroquel, Risperdal, and Zyprexa. Based on psychotherapy, the market can be segmented into abnormal psychology, social psychology, biological psychology, and others.
Geographically, the global psychosis treatment market has been divided into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market, owing to high incidence of schizophrenia and depression among the people in the region. Europe is the second-largest market for psychosis treatment. Presence of several psychotherapy associations such as British Association for Counselling & Psychotherapy drives the market in Europe. In addition, India, Southeast Asia, and China are emerging markets for psychiatry therapies, due to changing lifestyle coupled with increasing awareness about psychological diseases among the people in these countries.
Request For TOC @ https://www.marketresearchreports.biz/sample/toc/8330
Key players operating in the global psychosis treatment market are Eli Lilly, Bristol-Meyer Squibb, GlaxoSmithKline, Pfizer, AstraZeneca, Universal Health Services Inc., Johnson & Johnson, Bristol-Meyer Squibb, Wyeth, and Astellas Pharma Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207